Ascent Group LLC decreased its position in JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report) by 13.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 12,697 shares of the company’s stock after selling 1,941 shares during the quarter. Ascent Group LLC’s holdings in JPMorgan International Research Enhanced Equity ETF were worth $838,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Csenge Advisory Group boosted its position in shares of JPMorgan International Research Enhanced Equity ETF by 18.4% in the 2nd quarter. Csenge Advisory Group now owns 28,818 shares of the company’s stock worth $1,804,000 after purchasing an additional 4,480 shares in the last quarter. Buffington Mohr McNeal increased its holdings in shares of JPMorgan International Research Enhanced Equity ETF by 4.0% during the second quarter. Buffington Mohr McNeal now owns 259,883 shares of the company’s stock valued at $16,269,000 after acquiring an additional 9,896 shares in the last quarter. U.S. Capital Wealth Advisors LLC raised its position in shares of JPMorgan International Research Enhanced Equity ETF by 25.4% in the 2nd quarter. U.S. Capital Wealth Advisors LLC now owns 48,950 shares of the company’s stock worth $3,064,000 after purchasing an additional 9,929 shares during the last quarter. Shira Ridge Wealth Management grew its position in JPMorgan International Research Enhanced Equity ETF by 16.2% during the 2nd quarter. Shira Ridge Wealth Management now owns 4,883 shares of the company’s stock valued at $306,000 after purchasing an additional 681 shares during the last quarter. Finally, Cliftonlarsonallen Wealth Advisors LLC increased its stake in JPMorgan International Research Enhanced Equity ETF by 9.4% during the 2nd quarter. Cliftonlarsonallen Wealth Advisors LLC now owns 250,899 shares of the company’s stock valued at $15,706,000 after purchasing an additional 21,596 shares in the last quarter.
JPMorgan International Research Enhanced Equity ETF Stock Performance
Shares of NYSEARCA JIRE opened at $62.71 on Wednesday. The company has a market cap of $6.26 billion, a PE ratio of 16.01 and a beta of 0.84. The firm’s 50 day moving average price is $63.26 and its 200-day moving average price is $63.57. JPMorgan International Research Enhanced Equity ETF has a 52-week low of $56.46 and a 52-week high of $67.10.
JPMorgan International Research Enhanced Equity ETF Company Profile
The JPMorgan International Research Enhanced Equity ETF (JIRE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that provides exposure to stocks of any market capitalization from developed markets, excluding North America. JIRE was launched on Jun 10, 2022 and is managed by JPMorgan Chase.
Further Reading
- Five stocks we like better than JPMorgan International Research Enhanced Equity ETF
- When to Sell a Stock for Profit or Loss
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Investing in Construction Stocks
- Netflix Is On Track To Hit $1,000 By Christmas
- The Role Economic Reports Play in a Successful Investment Strategy
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Want to see what other hedge funds are holding JIRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report).
Receive News & Ratings for JPMorgan International Research Enhanced Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan International Research Enhanced Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.